Posted on: November 2, 2012 by Staff
Alethia Biotherapeutics Inc., a company developing “therapeutic monoclonal antibodies,” has added $4.7 million in new financing. Investors include AgeChem Venture Fund, BDC Venture Capital, GO Capital, and Cellscript of Wisconsin. Alethia Biotherapeutics is based in Montreal.
Tags: AgeChem Venture Fund, Alethia Biotherapeutics Inc., BDC Venture Capital, Canada, Cellscript, GO Capital
Posted on: June 13, 2011 by cnolan
Milestone Pharmaceuticals Inc., a Montreal-based cardiovascular drug development company, has raised $13 million in fresh capital. Pappas Ventures, the Business Development Bank of Canada and GO Capital co-led the round. Fonds de solidarité FTQ, iNovia Healthcare Ventures and Fonds Bio-Innovation also participated. The money will be used for continued development. As a result of the round, Eric Linsley, managing partner of Pappas Ventures; Scott Weiner, senior principal at Pappas Ventures; and Dominic Jaikaran, principal at BDC Health Venture Fund, will join Milestone’s board.
Tags: Business Development Bank of Canada, Fonds Bio-Innovation, Fonds de solidarité FTQ, GO Capital, iNovia Healthcare Ventures, Pappas Ventures